Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease
Abstract A growing body of literature describes the anti-inflammatory, neuroprotective, and anti-epileptic properties of the cannabis sativa constituent cannabidiol, suggesting…
